Extracellular activation of HCN4 by a subtype-specific nanobody

Hyperpolarization-activated cyclic nucleotide-gated channels (HCN1-4) control cardiac and neuronal firing and their dysfunction leads to cardiac arrythmias (HCN4), epilepsy (HCN1) and chronic pain (HCN2). Prompted by the urgent need for HCN subtype-specific treatments, we screened a recombinant nanobody library in search of HCN4-specific binders. Here we show that nanobody 5 (NB5) binds to the extracellular side of HCN4 with high specificity and nanomolar affinity and activates the channel by a non-canonical electromechanical coupling path. In ex vivo and in vitro experiments, NB5 acts as an agonist of the pacemaker current I<sub>f</sub>, increasing the firing rate of rabbit cardiac pacemaker myocytes and of human derived cardiomyocytes. Notably in vitro, NB5 rescued the loss-of-function effects on HCN4 current caused by a mutation found in a patient with sinus node dysfunction. Our work illustrates that animal-free recombinant nanobodies have strong potential as next generation modulators for clinical application in symptomatic bradycardia.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-12-01
DOI
https://doi.org/10.1038/s41467-025-65852-3
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular activation of HCN4 by a subtype-specific nanobody

Alessandro Porro, Andrea Saponaro, Roberta Castelli, Gerhard Thiel et al.
Nature Communications
Monoclonal and Polyclonal Antibodies Research
article

Extracellular activation of HCN4 by a subtype-specific nanobody

Alessandro Porro, Andrea Saponaro, Roberta Castelli, Gerhard Thiel, Luca Palloni, Matteo E. Mangoni, Ana M. Gómez, Dario DiFrancesco, Albano C. Méli, Atiyeh Sadat Sharifzadeh, Anna Moroni, Romain Perrier, Pietro Mesirca, Nadia Mekrane, Hugo Benoit
article en

Abstract

Hyperpolarization-activated cyclic nucleotide-gated channels (HCN1-4) control cardiac and neuronal firing and their dysfunction leads to cardiac arrythmias (HCN4), epilepsy (HCN1) and chronic pain (HCN2). Prompted by the urgent need for HCN subtype-specific treatments, we screened a recombinant nanobody library in search of HCN4-specific binders. Here we show that nanobody 5 (NB5) binds to the extracellular side of HCN4 with high specificity and nanomolar affinity and activates the channel by a non-canonical electromechanical coupling path. In ex vivo and in vitro experiments, NB5 acts as an agonist of the pacemaker current I<sub>f</sub>, increasing the firing rate of rabbit cardiac pacemaker myocytes and of human derived cardiomyocytes. Notably in vitro, NB5 rescued the loss-of-function effects on HCN4 current caused by a mutation found in a patient with sinus node dysfunction. Our work illustrates that animal-free recombinant nanobodies have strong potential as next generation modulators for clinical application in symptomatic bradycardia.

Nature CommunicationsVol. 16(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), University of Milan (IT), Université de Montpellier (FR), Université Paris-Saclay (FR), Physiologie et Médecine Expérimentale du Coeur et des Muscles (FR), Laboratory Signaling and Cardiovascular Pathophysiology (FR), Institut de Génomique Fonctionnelle (FR), Bocconi University (IT)
European Commission, Agence Nationale de la Recherche, Fondation Leducq, Fondazione Telethon
Openalex Percentile: Top 48%
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.